IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 21 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q3 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $76 | -39.7% | 41,700 | -1.7% | 0.00% | – |
| Q2 2023 | $126 | +6.8% | 42,427 | 0.0% | 0.00% | – |
| Q1 2023 | $118 | -53.0% | 42,427 | -10.5% | 0.00% | -100.0% |
| Q4 2022 | $251 | -99.9% | 47,427 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $189,000 | +3.3% | 47,427 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $183,000 | – | 47,427 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 1,058,035 | $2,931 | 0.15% |
| Gradient Capital Advisors, LLC | 26,808 | $74,258 | 0.03% |
| WEST PACES ADVISORS INC. | 1,665 | $4,612 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 28,652 | $79,366 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 17,484 | $48,430 | 0.00% |
| CITIGROUP INC | 7 | $19 | 0.00% |
| MORGAN STANLEY | 533 | $1,476 | 0.00% |
| NATIONAL BANK OF CANADA /FI/ | 2,255 | $6,251 | 0.00% |
| WOLVERINE TRADING, LLC | 11,700 | $33 | 0.00% |